Stemtech Corporation
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Charles S. Arnold
- Full Time Employees
- 1
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 10370 USA Today Way Naples FL United States of America 33025
- IPO Date
- Nov 26, 2021
- CIK
- 0001511820
- Website
- stemtech.com
- Similar Companies
- Business
- Stemtech Corporation, a leading pioneer in the stemceutical industry, develops research-backed products to support the body's inherent stem cell functions across global markets. The company's specialized offerings are crafted to optimize the natural physiological processes of adult stem cells, facilitating their release from bone marrow, aiding their circulation throughout the bloodstream, and supporting their migration into tissues where they perform daily renewal for overall vitality. These plant-based nutritional supplements and personal care items, including the comprehensive RCM System featuring StemRelease3, StemFlo, and MigraStem, aim to promote healthy aging and immune system support. Stemtech also provides skincare solutions like DermaStem and OraStem for oral health, alongside its recently launched StemPets line for animal well-being. Distributing its portfolio through a direct sales model, the firm has expanded its reach across the Americas, Asia, Africa, and Europe, including recent strategic entries into India and Taiwan. Stemtech is headquartered in Naples, Florida.
Stemtech Secures Inventory Funding
Stemtech Revolution 2026: A Bold New Era In Global Wellness
Stemtech Corporation Launches New Market Channel Biosciences Ecommerce
Stemtech Corporation Welcomes Dr. Zahooruddin To Life Sciences Advisory Board
Stemtech Corporation Appoints Dr. Lizette Leos, MD To Chief Scientific Officer (CSO)
Stemtech Corporation - Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry
Stemtech Corporation Announces Entry Into India in a Joint Venture With Innoventure Dynamic LLP
Stemtech Corporation Backorders Filled
Stemtech Corporation Announces Exclusive Taiwan Distribution Licensing Agreement
Stemtech Corporation Announces Leading Clinical Physician To Research the Values of Stemtech RCM Products
Full Alliance Group's Pure Solutions Announces Manufacturing Agreement With Stemtech Corporation for New StemPets(TM) Product Line
Stemtech Corporation Announces Dr. Lizette Leos' "Well-Aging" Video Series
Stemtech Launches "StemPets(TM)" - the All-Natural Longevity Nutraceuticals Developed for Pets
Stemtech Corporation Announces Strategic Leadership Additions and Milestones Toward StemPets(TM) Launch in 2025
Stemtech Corporation: Leading The Global Wellness - Anti-Aging Healthy Revolution
Stemtech Corporation / Viago and Eevia Health Announce Proposed RTO
Stemtech Corporation and Seacret Direct / Viago Execute Merger Agreement
Stemtech Corporation and Viago Announce Strategic Merger
Stemtech Corporation Announces Uplist to OTCQB, Maintains Focus on Expansion and Transparency
Stemtech Expands Into The $303 Billion Pet Health Care Market With Launch Of Stempets(TM)